It has been reported to differentiate neural stem cells into dopaminergic neurons via upregulating the TET1 and FoxA2 expression and their binding, indicating potential application as neural stem cell replacement therapy for neurodegenerative diseases (Ye et al., 2020). Here, FOXA2 is linked to neurodegenerative disease.